Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus

Background and Objectives: Cutaneous lupus erythematosus (CLE) presents clinically heterogeneous manifestations, partially explained by the different expression of Toll-like receptors (TLRs) type 8 and 9, located to endosomal compartments where they are poised to recognize microbial nucleic acids. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Englert, Karolina A., Dyduch, Grzegorz, Kłosowicz, Agata, Spałkowska, Magdalena, Jaworek, Andrzej Kazimierz, Migacz-Gruszka, Kamila, Jarosz-Chudek, Aleksandra, Mercuri, Santo Raffaele, Szpor, Joanna, Mazzoccoli, Gianluigi, Damiani, Giovanni, Wojas-Pelc, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673105/
https://www.ncbi.nlm.nih.gov/pubmed/38004071
http://dx.doi.org/10.3390/medicina59112022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673105/
https://www.ncbi.nlm.nih.gov/pubmed/38004071
http://dx.doi.org/10.3390/medicina59112022

Ejemplares similares